Global Seasonal Affective Disorder Market Size, Status and Forecast 2021-2027

Seasonal Affective Disorder (SAD) is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between the ages of 15 to 55, and the people who live far from the equator where winter daylight hours are too short. Some major symptoms of this disorder are hopelessness, increased appetite, weight gain, loss of the ability to concentrate, social withdrawal etc. There are some risk factors associated with this disorder such as major depressive disorder, Bipolar I disorder, Bipolar II disorder, and others.
The Americas hold the largest share in the global Seasonal affective disorder market. North America dominates the market in this region. Approximately 5% of the US population is suffering from seasonal depression Some other factors such as changing lifestyle plays an important role in market growth. South America market is also growing significantly, especially growth is higher in countries such as Brazil due to increasing awareness about various mental disorders.

Market Analysis and Insights: Global Seasonal Affective Disorder Market
The global Seasonal Affective Disorder market size is projected to reach US$ 627.3 million by 2026, from US$ 531 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Seasonal Affective Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Seasonal Affective Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Seasonal Affective Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Seasonal Affective Disorder market.

Global Seasonal Affective Disorder Scope and Market Size
Seasonal Affective Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Light Therapy
Medications
Others

Segment by Application
Hospital
Clinic
Household
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie Inc. (US)
Allergan (Republic of Ireland)
Bayer AG (Germany)
Bristol-Myers Squibb Company (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Henry Schein(US)
Pfizer Inc. (US)